These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 15274293
1. CD105 inhibits transforming growth factor-beta-Smad3 signalling. Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S. Anticancer Res; 2004; 24(3a):1337-45. PubMed ID: 15274293 [Abstract] [Full Text] [Related]
2. Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells. Warrington K, Hillarby MC, Li C, Letarte M, Kumar S. Anticancer Res; 2005; 25(3B):1851-64. PubMed ID: 16158917 [Abstract] [Full Text] [Related]
7. Overexpression of CD105 in rat myoblasts: role of CD105 in cell attachment, spreading and survival. Guo B, Rooney P, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S. Int J Oncol; 2004 Aug 15; 25(2):285-91. PubMed ID: 15254724 [Abstract] [Full Text] [Related]
9. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH, Koziolek MJ, Vasko R, Schaefer L, Sharma K, Müller GA, Strutz F. Kidney Int; 2005 Jul 15; 68(1):96-109. PubMed ID: 15954899 [Abstract] [Full Text] [Related]
10. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J, Inoue K. Hepatology; 2003 Oct 15; 38(4):879-89. PubMed ID: 14512875 [Abstract] [Full Text] [Related]